Inventor · disambiguated record
Christopher Sean Straub
Also filed as: STRAUB CHRISTOPHER · STRAUB CHRISTOPHER S · STRAUB CHRISTOPHER SEAN
16 granted patents·11 pending applications·150 citations·filing 2005–2022
92Inventor score
Top patents by PatentIndex Score
27 records- 0196US7419975B2Organic compoundsNOVARTIS AG·Filed 2005·Granted Sep 2, 2008·80 cites·10 claims
- 0291US8552003B2(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their usesCHAREST MARK G·Filed 2007·Granted Oct 8, 2013·30 cites·4 claims
- 0390US8546336B2SMAC peptidometics useful as IAP inhibitorsCHEN ZHUOLIANG·Filed 2012·Granted Oct 1, 2013·15 cites·3 claims
- 0486US7989441B2Organic compoundsNOVARTIS AG·Filed 2006·Granted Aug 2, 2011·8 cites·8 claims
- 0585US8044209B2Pyrrolydine derivatives as IAP inhibitorsNOVARTIS AG·Filed 2007·Granted Oct 25, 2011·8 cites·10 claims
- 0684US11382905B2Immunomodulation by IAP inhibitorsNOVARTIS AG·Filed 2020·Granted Jul 12, 2022·1 cites·4 claims
- 0779US10786491B2Immunomodulation by IAP inhibitorsNOVARTIS AG·Filed 2017·Granted Sep 29, 2020·1 cites·6 claims
- 0875US8993523B2Dimeric IAP inhibitorsCHEN ZHUOLIANG·Filed 2011·Granted Mar 31, 2015·2 cites·35 claims
- 0974US2022296581A1Immunomodulation by IAP InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1069US8445440B2Dimeric IAP inhibitorsSTRAUB CHRISTOPHER·Filed 2011·Granted May 21, 2013·3 cites·42 claims
- 1166US8207183B2Inhibitors of IAPPALERMO MARK G·Filed 2011·Granted Jun 26, 2012·1 cites·15 claims
- 1266US7932255B22-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulatorsNOVARTIS AG·Filed 2006·Granted Apr 26, 2011·1 cites·10 claims
- 1360US8906936B2Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereofNOVARTIS AG·Filed 2013·Granted Dec 9, 2014·0 cites·6 claims
- 1459US9750729B2Immunomodulation by IAP inhibitorsZAWEL LEIGH·Filed 2009·Granted Sep 5, 2017·0 cites·19 claims
- 1557US2009005411A1Combinations of Organic CompoundsNOVARTIC AG·Filed 2006·Application pending·0 cites
- 1656US8048886B2Substituted pyrazine-3-one-derivatives as IAP inhibitorsNOVARTIS AG·Filed 2007·Granted Nov 1, 2011·0 cites·4 claims
- 1754US2014004101A1Smac peptidometics useful as iap inhibitorsCHEN ZHUOLIANG·Filed 2013·Application pending·0 cites
- 1853US2013085153A1Combination of an iap inhibitor and a taxane for the treatment of a proliferative diseaseJENSEN MICHAEL RUGAARD·Filed 2012·Application pending·0 cites
- 1952US2010324083A1Combinations of Organic CompoundsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2052US2023321067A1Dosing regimen comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivativesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2150US8058272B2Organic compoundsCHEN ZHUOLIANG·Filed 2007·Granted Nov 15, 2011·0 cites·2 claims
- 2250US2011281845A1Organic compoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
- 2349US8338440B2Inhibitors of IAPPALERMO MARK G·Filed 2012·Granted Dec 25, 2012·0 cites·17 claims
- 2445US2011319614A1Organic CompoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
- 2542US2011183955A12-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) ModulatorsNOVARTIS AG·Filed 2011·Application pending·0 cites
- 2640US2010316573A1Organic CompoundsGAITHER LARRY ALEXANDER·Filed 2007·Application pending·0 cites
- 2740US2013266590A1Dimeric iap inhibitorsSTRAUB CHRISTOPHER SEAN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →